Cite
Rubio-Viqueira B, Tarruella MM, Lázaro M, et al. PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study. Lung Cancer Manag. 2021;10(4):LMT53doi: 10.2217/lmt-2021-0008.
Rubio-Viqueira, B., Tarruella, M. M., Lázaro, M., Estévez, S. V., Córdoba-Ortega, J. F., Maiques, I. M., González, J. G., Cordellat, A. B., Valdivia-Bautista, J., Arenas, C. G., & Sánchez Torres, J. M. (2021). PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study. Lung cancer management, 10(4), LMT53. https://doi.org/10.2217/lmt-2021-0008
Rubio-Viqueira, Belen, et al. "PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study." Lung cancer management vol. 10,4 (2021): LMT53. doi: https://doi.org/10.2217/lmt-2021-0008
Rubio-Viqueira B, Tarruella MM, Lázaro M, Estévez SV, Córdoba-Ortega JF, Maiques IM, González JG, Cordellat AB, Valdivia-Bautista J, Arenas CG, Sánchez Torres JM. PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain: MOREL study. Lung Cancer Manag. 2021 Nov 26;10(4):LMT53. doi: 10.2217/lmt-2021-0008. eCollection 2021 Dec. PMID: 34899993; PMCID: PMC8656292.
Copy
Download .nbib